Table 1. Baseline characteristics of the 604 patients with autoimmune diseases treated with glucocorticoid.
n = 604(%) | |||
Females | 358(59.3) | ||
Mean age (years) | 59.5±16.8 | ||
BW (kg) | 55.9±10.9 | ||
Karnofsky score | 79.4±18.3 | ||
Primary disease | |||
Rheumatic disease | 313(51.8) | ||
SLE | 38(6.3) | ||
MCTD | 10(1.7) | ||
Polymyositis | 18(3.0) | ||
Drmatomyositis | 16(2.6) | ||
Vasculitis | 46(7.6) | ||
Behçet's disease | 5(0.8) | ||
Systemic sclerisis | 12(2.0) | ||
AOSD | 13(2.2) | ||
Sjögren's syndrome | 6(1.0) | ||
Rheumatoid arthritis | 136(22.5) | ||
Autoimmune bullous diseases | 7(1.2) | ||
Anaphylactoid purpura | 6(1.0) | ||
Neurological disease | 25(4.1) | ||
Multiple sclerosis | 4(0.7) | ||
Myasthenia gravis | 20(3.3) | ||
CIDP | 1(0.2) | ||
Gastro-Hepatobiliary disease | 79(13.1) | ||
Ulcerative colitis | 20(3.3) | ||
Autoimmune hepatitis | 51(8.4) | ||
Autoimmune pancreatitis | 4(0.7) | ||
PBC | 4(0.7) | ||
Interstitial lung disease | 133(22.0) | ||
Primary Glomerular disease | 54(8.9) | ||
Rapidly progressive glomerulonephritis | 7(1.2) | ||
Chronic glomerulonephritis | 18(3.0) | ||
Nephrotic syndrome | 29(4.8) | ||
Previous TB | 34(5.6) | ||
Co-morbidity | |||
Cardiovascular disease | |||
CVA | 20(3.3) | ||
Ischemic heart disease | 25(4.1) | ||
Hypertension | 128(21.2) | ||
Arrythmia | 19(3.1) | ||
Others | 12(2.0) | ||
Metabolic disease | |||
Hyperlipidemia | 149(24.7) | ||
Hyperuricemia | 44(7.3) | ||
Diabetes | 65(10.8) | ||
CKD | 32(5.3) | ||
Antimicrobial prophyraxis | |||
Isoniazid | 69(11.4) | ||
Trimethoprim-sulfamethoxazole | 138(22.8) |
Abbreviations: AOSD;Adult Onset Still's Disease, CIDP;Chronic inflammatory demyelinating polyneuropathy, CDK;Chronic kidney disease, CVA;Cerebro-vascular accident, SLE;Systemic lupus erythematosus, MCTD;Mixed connective-tissue disease, PBC;Primary biliary cirrhosis, TB;Tuberculosis Data are expressed as mean ± standard deviation or number (percentage).